Gregory H. Bailey - 07 Nov 2025 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Reporting relationship: Director
Issuer ticker: SER
Reported as of: 07 Nov 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Nov 2025, 20:05:48 UTC
Prior SEC filing: 07 May 2025
Next SEC filing: 17 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Gregory Bailey

Key filing fact

Gregory H. Bailey filed Form 4 for Serina Therapeutics, Inc. (SER) on 10 Nov 2025.

Key facts

This page summarizes Gregory H. Bailey's Form 4 filing for Serina Therapeutics, Inc. (SER).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Nov 2025, 20:05.

Change

Previous filing in this sequence was filed on 07 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001329505 Primary reporting owner

Bailey Gregory

Relationship: Director
Address: 601 GENOME WAY, SUITE 2001, HUNTSVILLE
Signature: /s/ Gregory Bailey
Signature date: 07 Nov 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SER transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +10,000
Change %
Price: $0.000000
Shares after: 10,000
Date: 07 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $3.91
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock options will vest on the earlier of (i) the day before the next Annual Meeting or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.